DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Abbasi MM, Monfaredan A, Hamishehkar H.
Seidi K, Jahanban- Esfahlan R. Novel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV modalities.
Asian Pac J Cancer Prev 2014;
15 (15) 6227-6232
We do not assume any responsibility for the contents of the web pages of other providers.